UBS AM’s HI-TECH PHARMACAL INC HITK Stock Holding History

UBS AM’s Portfolio HITK Stock Details HITK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-5,800	Closed	-$251K	–	2635
2014 Q1	$251K	Buy	+5,800	New	+$251K	﹤0.01%	2298

UBS AM's HITK Position: Q2 2014 in Review

UBS AM sold out of HI-TECH PHARMACAL INC (HITK) in Q2 2014, closing a stake of 5,800 shares — an estimated $251K sold.

UBS AM first reported a position in HITK in Q1 2014 and held it in 1 quarter. The position peaked at $251K in Q1 2014. 0 funds tracked by Wall St. Rank hold HITK as of Q2 2014.

UBS AM reported no remaining HI-TECH PHARMACAL INC position as of Q2 2014 after selling out during the quarter.
UBS AM sold 5,800 HI-TECH PHARMACAL INC shares in Q2 2014, an estimated $251K.
UBS AM first reported a position in HI-TECH PHARMACAL INC in Q1 2014 and held it in 1 quarter.
UBS AM's HI-TECH PHARMACAL INC position peaked at $251K in Q1 2014.
0 funds tracked by Wall St. Rank held HI-TECH PHARMACAL INC as of Q2 2014.

Based on UBS AM's 13F filing for Q2 2014, filed 13 Aug 2014.